Novel Treatment Strategies for Glioblastoma—A Summary
Glioblastoma (GBM) is the most common primary central nervous system tumor in adults, accounting for approximately 80% of all brain-related malignancies [...]
Guardado en:
Autor principal: | Stanley S. Stylli |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bb26b9a5629f402cac0474456841b955 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
EFNB1 Acts as a Novel Prognosis Marker in Glioblastoma through Bioinformatics Methods and Experimental Validation
por: Yaohong Shi, et al.
Publicado: (2021) -
Cancer Immunology and Immunotherapies: Mechanisms That Affect Antitumor Immune Response and Treatment Resistance
por: Xianda Zhao, et al.
Publicado: (2021) -
Comment on Kronenfeld et al. Clinical Outcomes for Primary and Radiation-Associated Angiosarcoma of the Breast with Multimodal Treatment: Long-Term Survival Is Achievable. <i>Cancers</i> 2021, <i>13</i>, 3814
por: Markus Notter, et al.
Publicado: (2021) -
Correction: Heterogeneity of subsets in glioblastoma mediated by Smad3 palmitoylation
por: Xiaoqing Fan, et al.
Publicado: (2021) -
Breast cancer risk in a rapidly aging population: advances and approaches to study the aging tissue microenvironment
por: Greco SJ
Publicado: (2019)